Vir Biotechnology, Inc. VIR Accumulated Depreciation
Accumulated Depreciation at other companies
Other financials
Where this comes from
Reported directly by Vir Biotechnology, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment.
The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vir Biotechnology, Inc.'s accumulated depreciation.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vir Biotechnology, Inc.'s accumulated depreciation?
- Vir Biotechnology, Inc. (VIR) reported accumulated depreciation of $49.9M in Q1 2026.
- How has Vir Biotechnology, Inc.'s accumulated depreciation changed year-over-year?
- Vir Biotechnology, Inc.'s accumulated depreciation increased by 28.4% year-over-year, from $38.87M to $49.9M.
- What is the long-term trend for Vir Biotechnology, Inc.'s accumulated depreciation?
- Over 3 years (2022 to 2025), Vir Biotechnology, Inc.'s accumulated depreciation has grown at a 31.5% compound annual growth rate (CAGR), from $20.74M to $47.16M.
- What does accumulated depreciation mean?
- Total accumulated depreciation on property, plant, and equipment since acquisition — represents the consumed portion of asset useful lives.